To motivate the population to participate in Phase 2 of the proof from homeland vaccinethe National Council for Science and Technology (Conacyt) highlighted the benefits of collaborating in the project, which include the delivery of 500 pesos as support for travel expenses.
The Conacyt posted a new video about him test clinical phase 2 of the homeland vaccine, which it develops in collaboration with Avimex. Although the call was opened on December 15, they are still recruiting volunteers.
For this reason, the Council highlighted the benefits of being part of the protocol: “In addition to collaborating in the development of the first Mexican vaccine against covid-19, there are advantages to being part of this study: medical expenses insurance, constant monitoring of the health status, medical studies such as electrocardiogram, blood pressure, oxygen levels and laboratory tests that include levels of glucose, cholesterol and triglycerides among others. Proof PCR in each visit and support of 500 pesos for travel expenses“.
He stressed that the vaccine has already passed the preclinical stages and phase 1 in humans, with “promising results to protect against the virus that causes covid-19.”
He explained that in this phase 2 the use of the vaccine as a reinforcement is evaluated, so those who are interested must meet requirements such as living in Mexico City, being 18 years of age or older, having received the vaccination scheme four months in advance. complete covid vaccination from any laboratory and not be participating in another study protocol.
The volunteers They must not have presented respiratory disease during the last 21 days, they must not be pregnant or breastfeeding, they must be in good general health and if they suffer from any chronic disease, it must be controlled.
Conacyt He explained that if the requirements are met, the candidates are assigned an appointment, where the protocol is indicated in detail, as well as the monitoring dates and at the end they have to sign an informed consent.
During the monitoring visits, the Conacyt indicated that the status of wills healtharyans, Laboratory samples will be taken, PCR tests, blood pressure control and oxygen levels will be carried out to know the body’s response to the vaccine.
According to Conacytin this second stage of the clinical protocol, 400 people will participate, half of them will receive Patria and the other half a placebo, with the commitment that weeks later they will apply another approved vaccine for reinforcement.
Just on February 14 last Conacytwhich heads Maria Elena Alvarez-Buyllaannounced the results of phase 1 of Patria, in which 90 participated volunteersto whom the homeland vaccine intramuscularly and nasally to find out which way is most effective.
The Patria project is several months late according to the calendar presented by Álvarez-Buylla in April of last year, since the original idea was that the 3 stages of clinical trials would be completed and by the end of 2021 it would already have authorization for emergency use.
kach
–
